National/B-ORG Patent/I-ORG Development/I-ORG Corp./I-ORG said/O it/O plans/O to/O purchase/O as/O many/O as/O 200,000/O common/O shares/O of/O its/O 81/O %/O -/O controlled/O Interferon/B-ORG Sciences/I-ORG Inc./I-ORG unit/O in/O periodic/O ,/O open/O -/O market/O purchases/O ./O
The/O 200,000/O shares/O are/O about/O 23/O %/O of/O Interferon/B-ORG 's/O common/O shares/O outstanding/O ,/O excluding/O National/B-ORG Patent/I-ORG 's/I-ORG stake/O ./O
Noting/O the/O recent/O Food/B-ORG and/I-ORG Drug/I-ORG Administration/I-ORG approval/O of/O Interferon/B-ORG 's/O genital/O warts/O treatment/O ,/O National/B-ORG Patent/I-ORG said/O it/O believes/O Interferon/B-ORG 's/O stock/O is/O undervalued/O ./O
